INC Research has signed on to use goBalto's web-based software to boost the process of getting clinical trials up and running, providing the Bay Area startup with what appears to be one of its biggest customer wins yet for the tech.
San Francisco-based goBalto, founded in 2008, has banked heavily on its Tracker software to become a leading tool for streamlining the tedious process of green-lighting a clinical trial. Last month, Qualcomm and others pledged $12 million for the startup's Series B round to advance the software.
GoBalto is delivering on part of its deal--help customers. Raleigh, NC-based INC, a global CRO with nearly 5,000 employees, plans to use Tracker 2.0 as part of its process of activating clinical trial sites. This puts the software developers tool, announced in March 2011, in the hands of study managers and helps keep sites and pharma sponsors on the same page during the trial startup process.
"The system creates efficiencies through streamlined communication among sites, sponsors and CROs," Alistair Macdonald, INC's COO, said in a statement. "This ultimately drives shorter timelines and cost savings for our customers."
Cloud software like goBalto's sounds cool, but it's the accumulation of customers that fuels tech startups.
- here's the release